Delayed remediation and patch latency are no longer just IT and security metrics; they serve as direct reflections of leadership priorities.
The post The Hidden Cost of Slow Cyber Remediation in Healthcare appeared first on MedCity News.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
